Delivery Order SPE2DB20D3101-SPE2DB25FRJM9
- Not listed
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,825.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $49,585.69 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this...
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors. This is a firm fixed-price contract with an ultimate completion date of May 21, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.27 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections (0.5 mL), with an ultimate completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors (0.5 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $2,029.53 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The contract carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a ceiling value of $132,811.30. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used in this award, indicating it was competitively awarded. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,766.11 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRJM9Delivery Order
The Defense Logistics Agency awarded a $1,632.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). The contract was competitively awarded with no set-aside designation and maintains an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order falls within the broader scope of AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to distribute a wide range of medications and medical supplies to support military healthcare systems globally. Mounjaro, a diabetes medication, aligns with the contractor's portfolio of therapeutic products including specialty medications, brand-name and generic drugs, and injectable delivery systems. As a prime vendor under the DLA Troop Support Medical program, AmerisourceBergen Drug Corp serves critical federal healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/5/25 |